Literature DB >> 24829862

Bone metastases: When and how lung cancer interacts with bone.

Ilaria Roato1.   

Abstract

BONE METASTASIS IS A COMMON AND DEBILITATING CONSEQUENCE OF LUNG CANCER: 30%-40% of patients with non-small cell lung cancer develop bone metastases during the course of their disease. Lung cancer cells find a favorable soil in the bone microenvironment due to factors released by the bone matrix, the immune system cells, and the same cancer cells. Many aspects of the cross-talk among lung tumor cells, the immune system, and bone cells are not clear, but this review aims to summarize the recent findings in this field, with particular attention to studies conducted to identify biomarkers for early detection of lung cancer bone metastases.

Entities:  

Keywords:  Bone metastases; Bone microenvironment; Lung cancer; Osteoclast; T cell

Year:  2014        PMID: 24829862      PMCID: PMC4014787          DOI: 10.5306/wjco.v5.i2.149

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  85 in total

1.  Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Authors:  M Neale Weitzmann; Cristiana Roggia; Gianluca Toraldo; Louise Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 3.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

4.  An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency.

Authors:  Michaela Robbie Ryan; Rebecca Shepherd; Jennifer K Leavey; Yuhao Gao; Francesco Grassi; Frederick J Schnell; Wei-Ping Qian; Gilbert J Kersh; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-02       Impact factor: 11.205

5.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

Review 6.  Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.

Authors:  Julie M Blair; Hong Zhou; Markus J Seibel; Colin R Dunstan
Journal:  Nat Clin Pract Oncol       Date:  2006-01

Review 7.  Targeting oxidative stress in cancer.

Authors:  Matthew W Lawless; Kenneth J O'Byrne; Steven G Gray
Journal:  Expert Opin Ther Targets       Date:  2010-11       Impact factor: 6.902

8.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

9.  Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Authors:  Toru Hiraga; Shinae Kizaka-Kondoh; Kiichi Hirota; Masahiro Hiraoka; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

Review 10.  Osteoclasts and the immune system.

Authors:  Tomoki Nakashima; Hiroshi Takayanagi
Journal:  J Bone Miner Metab       Date:  2009-05-20       Impact factor: 2.626

View more
  23 in total

1.  Effects of DKK1 overexpression on bone metastasis of SBC-3 cells.

Authors:  Hailin Pang; Ningqiang Ma; Weiwei Shen; Qiang Zhao; Jianlin Wang; Lian Duan; Wenjuan Chen; Ning Zhang; Zhengwei Zhao; Lili Liu; Helong Zhang
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

2.  Early osteosclerotic changes predict chemotherapy response in non-small-cell lung cancer patients with bone metastases.

Authors:  Dailin Rong; Yize Mao; Qiuxia Yang; Shuhang Xu; Qianqian Zhao; Rong Zhang
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

3.  Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.

Authors:  Oshrat Attar-Schneider; Victoria Zismanov; Liat Drucker; Maya Gottfried
Journal:  Tumour Biol       Date:  2015-10-30

4.  Risk factor analysis of bone metastasis in patients with non-small cell lung cancer.

Authors:  Yang Li; Chongqing Xu; Qiquan Yu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 5.  Gastric cancer: The times they are a-changin'.

Authors:  Maria Antonietta Satolli; Lucio Buffoni; Rosella Spadi; Ilaria Roato
Journal:  World J Gastrointest Oncol       Date:  2015-11-15

Review 6.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

7.  Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment.

Authors:  Thierry Guillaudeux; Rémy Pedeux; Ulrich Jarry; Mégane Bostoën; Raphaël Pineau; Laura Chaillot; Valentine Mennessier; Pierre Montagne; Emilie Motte; Marjorie Gournay; Arnaud Le Goff
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

Review 8.  Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment.

Authors:  Qiujun Guo; Jinyin Lin; Rui Liu; Yebo Gao; Shulin He; Xinyao Xu; Baojin Hua; Conghuang Li; Wei Hou; Honggang Zheng; Yanju Bao
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-10       Impact factor: 2.629

9.  Pattern of distant metastases in colorectal cancer: a SEER based study.

Authors:  Miaozhen Qiu; Jianming Hu; Dajun Yang; David Peter Cosgrove; Ruihua Xu
Journal:  Oncotarget       Date:  2015-11-17

10.  Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.

Authors:  Xu Guo; Wenjuan Ma; Haixiao Wu; Yao Xu; Dezheng Wang; Shuang Zhang; Zheng Liu; Vladimir P Chekhonin; Karl Peltzer; Jin Zhang; Xin Wang; Chao Zhang
Journal:  BMC Cancer       Date:  2021-05-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.